• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Layoffs: Medtronic to cut another 500 jobs in hopes of saving $125M per year

Layoffs: Medtronic to cut another 500 jobs in hopes of saving $125M per year

September 6, 2012 By MassDevice staff

Medtronic logo

Medtronic (NYSE:MDT) is halfway through a 2012 restructuring plan in which the company expects to let go of 1,000 employees from divisions around the world.

The initial 500 positions were cut before the end of July, with another 500 to go before the end of 4th quarter of 2013, according to the company’s latest financial report.

The layoffs are designed to save general, administrative and indirect distribution costs from certain business units so that Medtronic can focus its attention in areas where it expects faster growth, such as in emerging markets and new therapies, the medical device company reported.

Medtronic expects the cuts to save $100-$125 million per year in savings, most of that coming from reduced compensation expenses.

The medtech giant 1st announced the cuts in May in conjunction with its 4th quarter and full-year earnings report, in which the company noted a continued decline in U.S. cardiac rhythm management and spinal products.

The layoffs included 200 from the device maker’s cardiac rhythm management division, but the remainder were not identified.

"We are eliminating about 1,000 positions around the company and around the globe," chief financial officer Gary Ellis said at the time. "It’s kind of the normal, ongoing thing that goes forward as we shift resources from slower-growing markets to faster-growing markets."

Medtronic has struggled with its heart business as the U.S. CRM market lagged for several quarters, but, despite a 5% sales slide during its latest quarter, the device giant said the slump seems to have stabilized.

Medtronic will add 1,500 new employees during fiscal year 2013, leaving a net increase in its workforce, Bloomberg News reported.

Medtronic’s workforce grew by about 4.7% from 2011 to 2012, according to data compiled by MassDevice.com.

Medtronic recorded a Q4 $118 million restructuring charge in connection with the ongoing layoffs, including $66 million in employee termination costs, $9 million in asset write-downs, $30 million in contract termination costs and $13 million in related expenses, according to the SEC filing.

MDT shares were up 1.7% to $41.53 as of about 1:30 p.m. today.

Filed Under: News Well Tagged With: Layoffs

More recent news

  • Former Shockwave Medical CEO joins Solenic Medical’s board
  • Anaconda Biomed brings in $56 million
  • Precision Neuroscience raises $250M in Series D for its BCI
  • Fresenius discontinuing Chinese sales of 4008A hemodialysis system
  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy